AVB-S6-500
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AVB-S6-500, covering 2022-02-10 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma [Phase 1]